Ono Pharmaceutical Co., Ltd.
Clinical trials sponsored by Ono Pharmaceutical Co., Ltd., explained in plain language.
Japanese pharmaceutical company focused on oncology and immunology.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Could a new pill tame ulcerative colitis? a First-in-Human trial aims to find out
Disease control Not yet recruitingThis early-stage trial evaluates an investigational oral drug called ONO-6414 in healthy adults and in people with active ulcerative colitis. The main goals are to assess the drug's safety, tolerability, and how the body processes it. The study includes single and multiple doses,…
Phase: PHASE1 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new drug shrink Hard-to-Treat childhood cancers?
Disease control Not yet recruitingThis trial is testing an experimental drug called ONO-4538HSC (nivolumab) in children with advanced solid tumors that have not responded to standard treatments, and in patients with epithelioid sarcoma. The goal is to see if the drug is safe, tolerable, and effective at shrinking…
Phase: PHASE1, PHASE2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC